This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n9http://localhost/temp/predkladatel/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n8http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11120%2F12%3A43906849%21RIV13-MSM-11120___/
n15http://linked.opendata.cz/resource/domain/vavai/subjekt/
n14http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n17http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11120%2F12%3A43906849%21RIV13-MSM-11120___
rdf:type
skos:Concept n14:Vysledek
dcterms:description
Several treatment guidelines are available for clinicians working with patients with bipolar disorder (BD), but some of the more nuanced aspects of lithium therapy go beyond the scope of such guidelines. Therefore, in this perspective, our objective was to focus on specific practical issues of lithium treatment, including the selection and initiation of long-term treatment, and management and discontinuation (if indicated) of lithium prophylaxis. Method: We conducted a focused review of the relevant literature on the treatment of BD. Results: Consultation requests to a BD specialty service often relate to issues for which there is limited evidence, including when to initiate long-term treatment, whether choice of mood stabilizer is specific, how long to treat acute episodes, whether to switch or add on medication when treatment fails, how long to continue effective treatment, and what medication to use when a lithium-responsive patient must discontinue lithium. Conclusion: Optimal long-term treatment of BD will require more research as well as better alignment of clinical and training programs. Several treatment guidelines are available for clinicians working with patients with bipolar disorder (BD), but some of the more nuanced aspects of lithium therapy go beyond the scope of such guidelines. Therefore, in this perspective, our objective was to focus on specific practical issues of lithium treatment, including the selection and initiation of long-term treatment, and management and discontinuation (if indicated) of lithium prophylaxis. Method: We conducted a focused review of the relevant literature on the treatment of BD. Results: Consultation requests to a BD specialty service often relate to issues for which there is limited evidence, including when to initiate long-term treatment, whether choice of mood stabilizer is specific, how long to treat acute episodes, whether to switch or add on medication when treatment fails, how long to continue effective treatment, and what medication to use when a lithium-responsive patient must discontinue lithium. Conclusion: Optimal long-term treatment of BD will require more research as well as better alignment of clinical and training programs.
dcterms:title
Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment With Lithium Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment With Lithium
skos:prefLabel
Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment With Lithium Beyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment With Lithium
skos:notation
RIV/00216208:11120/12:43906849!RIV13-MSM-11120___
n14:predkladatel
n15:orjk%3A11120
n3:aktivita
n18:N
n3:aktivity
N
n3:cisloPeriodika
7
n3:dodaniDat
n17:2013
n3:domaciTvurceVysledku
n11:8421382
n3:druhVysledku
n7:J
n3:duvernostUdaju
n13:S
n3:entitaPredkladatele
n8:predkladatel
n3:idSjednocenehoVysledku
124799
n3:idVysledku
RIV/00216208:11120/12:43906849
n3:jazykVysledku
n16:eng
n3:klicovaSlova
mood stabilizer; lithium; bipolar disorder
n3:klicoveSlovo
n5:bipolar%20disorder n5:mood%20stabilizer n5:lithium
n3:kodStatuVydavatele
CA - Kanada
n3:kontrolniKodProRIV
[2A3609267CF1]
n3:nazevZdroje
Canadian Journal of Psychiatry - Revue Cannadiene de Psychiatrie
n3:obor
n6:FL
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n17:2012
n3:svazekPeriodika
57
n3:tvurceVysledku
Alda, Martin
n3:wos
000306621800007
s:issn
0706-7437
s:numberOfPages
9
n9:organizacniJednotka
11120